146 related articles for article (PubMed ID: 19846820)
1. The Becton Dickinson FocalPoint GS Imaging System: clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions.
Wilbur DC; Black-Schaffer WS; Luff RD; Abraham KP; Kemper C; Molina JT; Tench WD
Am J Clin Pathol; 2009 Nov; 132(5):767-75. PubMed ID: 19846820
[TBL] [Abstract][Full Text] [Related]
2. Assisted primary screening using the automated ThinPrep Imaging System.
Biscotti CV; Dawson AE; Dziura B; Galup L; Darragh T; Rahemtulla A; Wills-Frank L
Am J Clin Pathol; 2005 Feb; 123(2):281-7. PubMed ID: 15842055
[TBL] [Abstract][Full Text] [Related]
3. FocalPoint slide classification algorithms show robust performance in classification of high-grade lesions on SurePath liquid-based cervical cytology slides.
Parker EM; Foti JA; Wilbur DC
Diagn Cytopathol; 2004 Feb; 30(2):107-10. PubMed ID: 14755762
[TBL] [Abstract][Full Text] [Related]
4. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
Wilgenbusch H; Mueller G; Neal M; Renshaw AA
Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
[TBL] [Abstract][Full Text] [Related]
5. Proposed Sheffield quantitative criteria in cervical cytology to assist the diagnosis and grading of squamous intra-epithelial lesions, as some Bethesda system definitions require amendment.
Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
Cytopathology; 2005 Aug; 16(4):168-78. PubMed ID: 16048503
[TBL] [Abstract][Full Text] [Related]
6. Liquid-based cervical cytology.
Klinkhamer PJ; Meerding WJ; Rosier PF; Hanselaar AG
Cancer; 2003 Oct; 99(5):263-71. PubMed ID: 14579292
[TBL] [Abstract][Full Text] [Related]
7. Location-guided screening of liquid-based cervical cytology specimens: a potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial.
Wilbur DC; Parker EM; Foti JA
Am J Clin Pathol; 2002 Sep; 118(3):399-407. PubMed ID: 12219782
[TBL] [Abstract][Full Text] [Related]
8. Results of the implementation of liquid-based cytology-SurePath in the Ontario screening program.
Colgan TJ; McLachlin CM; Cotterchio M; Howlett R; Seidenfeld AM; Mai VM
Cancer; 2004 Dec; 102(6):362-7. PubMed ID: 15481083
[TBL] [Abstract][Full Text] [Related]
9. Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosis.
Ronco G; Vineis C; Montanari G; Orlassino R; Parisio F; Arnaud S; Berardengo E; Fabbrini T; Segnan N
Cancer; 2003 Apr; 99(2):83-8. PubMed ID: 12704687
[TBL] [Abstract][Full Text] [Related]
10. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
Wertlake P
J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
[TBL] [Abstract][Full Text] [Related]
11. Implementation of FocalPoint GS location-guided imaging system: experience in a clinical setting.
Levi AW; Chhieng DC; Schofield K; Kowalski D; Harigopal M
Cancer Cytopathol; 2012 Apr; 120(2):126-33. PubMed ID: 22505211
[TBL] [Abstract][Full Text] [Related]
12. Increasing cytotechnologist workload above 100 slides per day using the ThinPrep imaging system leads to significant reductions in screening accuracy.
Elsheikh TM; Kirkpatrick JL; Cooper MK; Johnson ML; Hawkins AP; Renshaw AA
Cancer Cytopathol; 2010 Apr; 118(2):75-82. PubMed ID: 20151428
[TBL] [Abstract][Full Text] [Related]
13. Use of the ThinPrep Imaging System for internal quality control of cervical cytology.
Heard T; Chandra A; Culora G; Gupta SS; Herbert A; Morgan M
Cytopathology; 2013 Aug; 24(4):246-53. PubMed ID: 22937891
[TBL] [Abstract][Full Text] [Related]
14. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
Caraway NP; Khanna A; Dawlett M; Guo M; Guo N; Lin E; Katz RL
Gynecol Oncol; 2008 Jul; 110(1):37-42. PubMed ID: 18433848
[TBL] [Abstract][Full Text] [Related]
15. A three-armed trial of the ThinPrep Imaging System.
Roberts JM; Thurloe JK; Bowditch RC; Hyne SG; Greenberg M; Clarke JM; Biro C
Diagn Cytopathol; 2007 Feb; 35(2):96-102. PubMed ID: 17230572
[TBL] [Abstract][Full Text] [Related]
16. A validation study of the FocalPoint GS imaging system for gynecologic cytology screening.
Colgan TJ; Bon N; Clipsham S; Gardiner G; Sumner J; Walley V; McLachlin CM
Cancer Cytopathol; 2013 Apr; 121(4):189-96. PubMed ID: 23361915
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of AutoPap system location-guided screening in the evaluation of cervical cytology smears.
Stevens MW; Milne AJ; Parkinson IH; Nespolon WW; Fazzalari NL; Arora N; Dodd TJ
Diagn Cytopathol; 2004 Aug; 31(2):94-9. PubMed ID: 15282720
[TBL] [Abstract][Full Text] [Related]
18. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
Djemli A; Khetani K; Auger M
Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of rapid prescreening and 10% rescreening in liquid-based Papanicolaou testing.
Currens HS; Nejkauf K; Wagner L; Raab SS
Am J Clin Pathol; 2012 Jan; 137(1):150-5. PubMed ID: 22180489
[TBL] [Abstract][Full Text] [Related]
20. Direct-to-vial comparison of a new liquid-based cytology system, liqui-PREP versus the conventional pap smear.
Park J; Jung EH; Kim C; Choi YH
Diagn Cytopathol; 2007 Aug; 35(8):488-92. PubMed ID: 17636495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
